Brief: Polynovo Receives FDA 510(K) Clearance For Novosorb Mtx

Polynovo

19/09/2022 02:32

Sept 19 (Reuters) - Polynovo Ltd  PNV.AX :
    * RECEIVED FDA 510(K) CLEARANCE FOR NOVOSORB MTX FOR SOFT
TISSUE
REGENERATION FOR MANAGEMENT OF COMPLEX WOUNDS

Source text for Eikon:  ID:nASX6GkxvK 
Further company coverage:  PNV.AX